ADA COMPLETE Trademark

Trademark Overview


On Wednesday, September 7, 2022, a trademark application was filed for ADA COMPLETE with the United States Patent and Trademark Office. The USPTO has given the ADA COMPLETE trademark a serial number of 97581840. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 27, 2024. This trademark is owned by AbbVie Biotechnology Ltd. The ADA COMPLETE trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof; none of the foregoing services in the field of oral or dental health

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites; none of the foregoing services in the field of oral or dental health
ada complete

General Information


Serial Number97581840
Word MarkADA COMPLETE
Filing DateWednesday, September 7, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof; none of the foregoing services in the field of oral or dental health
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites; none of the foregoing services in the field of oral or dental health

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, September 13, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 13, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPembroke HM11
BM

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 27, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, October 29, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sunday, October 29, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, August 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 7, 2023NON-FINAL ACTION E-MAILED
Monday, August 7, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 21, 2023ASSIGNED TO EXAMINER
Tuesday, May 23, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, May 23, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 10, 2022NEW APPLICATION ENTERED